RxDoctor Payments Data

Daniel Choi

Oral and Maxillofacial Surgery · Boston, MANPI 1881836542

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (54.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Nexus CMF, LLC accounts for 86.6% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $12,608 and has fallen 99.3% since, to $85 in 2025. Among oral and maxillofacial surgery clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$47,880in general payments, 2019–2025

Across 88 payments — averaging $544.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nexus CMF, LLC$41K
  • Kairos Surgical Inc$4K
  • Axogen$2K
  • Kls-martin L.p.$273
  • Arthrex$263
  • Stryker$108
  • plus $121 from 5 others

What the payments were for

  • Consulting fees$26,00054%
  • Travel & lodging$14,50630%
  • Food & beverage$3,7748%
  • Education$3,6008%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$47,880 in reported general payments places this provider in the 95th percentile of 247 oral and maxillofacial surgery providers in Massachusetts.

See all oral and maxillofacial surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$77,168
Medicare patients
144
Services billed
461

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ampicillin-SulbactamAmpicillin Sod/Sulbactam Sod14$2,352

Paid to pharmacies, not to this prescriber.

Other oral and maxillofacial surgery in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →